Skip to main content
. 2022 Jun 21;12:10458. doi: 10.1038/s41598-022-13508-3

Table 3.

Comparative Performance on blindtest sets between BRCA1/2 classification models and other alternative predictors.

Methods ACC MCC Sens Spec ROC-AUC
BRCA1 SIFT10 0.67 0.62 76% 64% 0.81
PolyPhen-213 0.68 0.41 68% 59% 0.71
Align-GVGD19,20 0.48 0.18 48% 26% 0.64
REVEL13 0.41 0.18 41% 20% 0.54
CADD40 0.74 0.58 74% 59% 0.80
Our model 0.86 0.89 92% 82% 0.95
BRCA1-combined SIFT10 0.67 0.62 76% 64% 0.81
PolyPhen-213 0.68 0.41 68% 59% 0.71
Align-GVGD19,20 0.40 0.18 38% 23% 0.64
REVEL13 0.41 0.18 41% 21% 0.54
CADD40 0.74 0.58 73% 59% 0.80
Our model 0.94 0.89 100% 91% 0.95
BRCA2 SIFT10 0.62 0.42 62% 52% 0.76
PolyPhen-213 0.58 0.40 58% 48% 0.74
Align-GVGD19,20 0.39 0.34 38% 24% 0.62
REVEL13 0.84 0.51 85% 86% 0.82
CADD40 0.58 0.58 58% 48% 0.74
Our model 0.92 0.89 60% 100% 0.98
BRCA2-combined SIFT10 0.74 0.51 74% 70% 0.85
PolyPhen-213 0.69 0.46 69% 64% 0.82
Align-GVGD19,20 0.46 0.28 46% 36% 0.68
REVEL13 0.87 0.61 86% 88% 0.86
CADD40 0.74 0.58 74% 70% 0.85
Our model 0.97 0.83 86% 100% 0.98
BRCA1/2-general model SIFT10 0.69 0.52 69% 59% 0.79
PolyPhen-213 0.65 0.47 65% 54% 0.77
Align-GVGD19,20 0.44 0.19 44% 30% 0.59
REVEL13 0.82 0.64 82% 78% 0.86
CADDyyy40 0.69 0.58 69% 59% 0.79
Our model 0.92 0.76 93% 100% 0.95